首页> 外国专利> Administration of ATIII by inhalation provides more efficient treatment of lung disorders such as lung inflammation and injury than intravenous administration

Administration of ATIII by inhalation provides more efficient treatment of lung disorders such as lung inflammation and injury than intravenous administration

机译:通过吸入施用ATIII可以比静脉内施用更有效地治疗肺部疾病,例如肺部炎症和损伤

摘要

Disclosed is the use of antithrombin III as a sole ingredient in the manufacture of an inhalation medicament for treating acute lung injury in a patient in need thereof, particularly when the medicament is formulated to provide a does of about 25-125 U/kg of body weight.
机译:公开了抗凝血酶III作为唯一成分在制备用于治疗需要其的患者的急性肺损伤的吸入药物中的用途,特别是当该药物被配制为提供约25-125U / kg的剂量时重量。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号